BridgeBio Pharma, Inc. (BBIO) Form 10-Q Quarterly Reports
BridgeBio Pharma, Inc. (BBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BBIO
CIK: 1743881
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 5/17/2019 12:00:00 AM
Lead Engagement PartnerJennifer Ciszewski
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-13 | 2026-10-06 | 8-K | 0001140361-26-039334 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | FORM 4 | 0001470831-26-000897 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | 8-K | 0001140361-26-035055 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0001470831-26-000848 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001950047-26-008424 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-16 | FORM 4 | 0001470831-26-000837 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-16 | FORM 4 | 0001470831-26-000836 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-16 | FORM 4 | 0001470831-26-000835 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008337 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-17 | — | SCHEDULE 13D/A Filing | 0001140361-26-033404 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008246 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-13 | 8-K | 0001140361-26-033282 | View SEC Doc Filr Page |
| 424B7 | 2026-08-14 | — | 424B7 | 0001140361-26-032934 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001743881-26-000027 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001743881-26-000026 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | FORM 4 | 0001470831-26-000745 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0000908834-26-000369 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002210 | View SEC Doc Filr Page |
| S-3ASR | 2026-07-24 | — | S-3ASR | 0001140361-26-029624 | View SEC Doc Filr Page |
| S-8 | 2026-07-24 | — | S-8 | 0001140361-26-029623 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-22 | 8-K | 0001140361-26-029291 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | FORM 4 | 0001470831-26-000709 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | FORM 4 | 0001470831-26-000708 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-10 | — | SCHEDULE 13D/A Filing | 0000905148-26-003237 | View SEC Doc Filr Page |
| 144 | 2026-07-09 | — | 144 Filing | 0001950047-26-006979 | View SEC Doc Filr Page |